Application of miR-584-5p as biomarker for acute respiratory distress syndrome
A kind of acute respiratory distress, biomarker technology, applied in the field of biotechnology and medicine, can solve the problems of patient trauma, inconvenient material collection, etc., to achieve the effect of assisting ARDS pathological identification and clinical diagnosis, and good clinical application prospects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0028] The ARDS serum samples used in this example (including 11 serum samples at the onset of ARDS patients and 10 serum samples at the time of death of ARDS patients) came from patients who received treatment at Xixi Hospital, Hangzhou City, Zhejiang Province between December 2013 and February 2016. Whole blood from patients with ARDS. Enrolled patients are required to be older than or equal to 18 years old, with sound heart function, and non-pregnant and lactating patients. The normal serum control samples used in the present invention come from healthy volunteers (20 cases).
[0029] Reagents used in this example, such as chloroform, isopropanol, ethanol, DNA polyacrylamide gel electrophoresis reagents and other conventional biochemical reagents, were purchased from Shanghai Sangong Company; PCR amplification reagents (containing 10 × buffer, dNTPs mixture) and reagents for reverse transcription, such as RNase inhibitor, M-MLV reverse transcriptase, 5×M-MLV buffer and dNTP...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com